<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045075"><TermName>NB1011</TermName><TermDefinition><DefinitionText>A substance that is being studied for its ability to make cancer cells respond to drugs to which they have become resistant. It is a type of nucleoside analog.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>NB1011</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio por su capacidad de hacer que las células respondan a los medicamentos a los que se han vuelto resistentes. Es un tipo de análogo de los nucleósidos.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2008-07-22</DateLastModified></GlossaryTerm>
